Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts
Authors:
- Sanne ReijmSRSanne Reijm
- Joanneke C. KwekkeboomJKJoanneke C. Kwekkeboom
- Nienke J. BlombergNBNienke J. Blomberg
- Jolien SuurmondJSJolien Suurmond
- Diane van der WoudeDWDiane van der Woude
- René E.M. ToesRTRené E.M. Toes
- Hans U. SchererHSHans U. Scherer
Open Access
- 23 October 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (20)
Abstract
Many autoimmune diseases (AIDs) are characterized by the persistence of autoreactive B cell responses, which have been directly implicated in disease pathogenesis. How and why these cells are generated or how they are maintained for years is largely unknown. Rheumatoid arthritis (RA) is among the most common AIDs and is characterized by autoantibodies recognizing proteins with posttranslational modifications (PTMs). This PTM-directed autoreactive B cell compartment is ill defined. Here, we visualized the B cell response against the three main types of PTM antigens implicated in RA by spectral flow cytometry. Our results showed extensive cross-reactivity of PTM-directed B cells against all three PTM antigens (citrulline, homocitrulline, and acetyllysine). Unsupervised clustering revealed several distinct memory B cell (mBC) populations. PTM-directed cells clustered with the most recently activated class-switched mBC phenotype, with high CD80, low CD24, and low CD21 expression. Notably, patients also harbored large fractions of PTM-directed plasmablasts (PBs). Both PTM-directed mBCs and PBs showed high expression of CXCR3, a receptor for chemokines present in abundance in arthritic joints. Together, our data provide detailed insight into the biology of B cell autoreactivity and its remarkable, seemingly exhaustless persistence in a prominent human AID.Keywords
Funding Information
- NWO gravitation program “Institute for Chemical Immunology” (NWO-024.002.009)
- IMI funded project RTCure (777357)
- Target to B! (LSHM18055-5GF)
- European Research Council (AdG2019-884796)
- NWO-ZonMW VIDI grant (09150172010067)
- NWO-ZonMW OffRoad Grant (451001012)
- ReumaNederland (17-1-402, LLP5, 15-2-402, 18-1-205)
This publication has 42 references indexed in Scilit:
- FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry dataCytometry Part A, 2015
- The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrationsAnnals of the Rheumatic Diseases, 2013
- B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapyBlood, 2010
- Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individualsJournal of Experimental Medicine, 2008
- The immune geography of IgA induction and functionMucosal Immunology, 2008
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensNew England Journal of Medicine, 2007
- Generation of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic CellsScience, 2006
- Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cellsBlood, 2005
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritisRheumatology International, 2004